[Shatin, Hong Kong] — [25/06/25] – Xellera Therapeutics, a leading provider of [biopharmaceutical/CDMO/advanced therapy] solutions, today announced the expansion of its Quality Control (QC) infrastructure to meet growing industry demands for regulatory compliance, precision testing, and product consistency.
The upgraded QC framework includes advanced analytical instrumentation, expanded laboratory space, and a highly trained scientific team focused on delivering robust, reliable data throughout every phase of product development and manufacturing. This strategic enhancement strengthens Xellera Therapeutics commitment to upholding global standards such as GMP, ICH, and FDA guidelines, ensuring clients receive products that meet the highest levels of safety and efficacy.

“Quality Control is not just a regulatory requirement—it’s the foundation of trust between manufacturers, healthcare providers, and patients,” said ,Xellera Therapeutics Enhances Quality Control Capabilities to Strengthen Regulatory Compliance and Product Integrity at Xellera Therapeutics. “By investing in QC, we ensure every lot meets the rigorous standards necessary for clinical success and market approval.”

The expanded QC capabilities support a wide range of applications, including:
Raw material and in-process testing
Microbiological analysis
Mycoplasma and endotoxin detection
Final product release testing
Stability studies and method validation
This development also aligns with Xellera Therapeutics growth in biologics, cell and gene therapies, and advanced therapy medicinal products (ATMPs), where quality oversight is critical due to the complexity and sensitivity of these modalities.

About Xellera Therapeutics
Xellera Therapeutics is a forward-thinking [biotech/CDMO/life sciences] company specializing in [cell therapy, biologics, or manufacturing services]. With a strong focus on innovation, compliance, and quality, it delivers end-to-end support for clients worldwide.

Media Contact:
Name: Xellera Therapeutics
Title: Xellera Therapeutics Enhances Quality Control Capabilities to Strengthen Regulatory Compliance and Product Integrity
Email Address: [email protected]
Phone Number: +852 2618 3356
Website URL: http://www.xelleratherapeutics.com